Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice. (2022)
Attributed to:
UoOxford Confidence in Concept 2013
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2022.819058
PubMed Identifier: 35529866
Publication URI: http://europepmc.org/abstract/MED/35529866
Type: Journal Article/Review
Volume: 13
Parent Publication: Frontiers in immunology
ISSN: 1664-3224